Cargando…
Use of a novel hemoadsorption device for cytokine removal as adjuvant therapy in a patient with septic shock with multi-organ dysfunction: A case study
CytoSorb(®) (CytoSorbents Corporation, USA) is a novel sorbent hemoadsorption device for cytokine removal. The aim of this study was to examine the clinical use of CytoSorb(®) in the management of patient with septic shock. We used this device as an adjuvant to stabilize a young patient with multi-o...
Autores principales: | Basu, Reshma, Pathak, Sunjay, Goyal, Jyoti, Chaudhry, Rajeev, Goel, Rati B., Barwal, Anil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4271283/ https://www.ncbi.nlm.nih.gov/pubmed/25538418 http://dx.doi.org/10.4103/0972-5229.146321 |
Ejemplares similares
-
Alteco endotoxin hemoadsorption in Gram-negative septic shock patients
por: Shum, HP, et al.
Publicado: (2013) -
Alteco endotoxin hemoadsorption in Gram-negative septic shock patients
por: Shum, Hoi Ping, et al.
Publicado: (2014) -
Experience with hemoadsorption (CytoSorb(®)) in the management of septic shock patients
por: Mehta, Yatin, et al.
Publicado: (2020) -
Effect of Hemoadsorption for Cytokine Removal in Pneumococcal and Meningococcal Sepsis
por: Leonardis, Francesca, et al.
Publicado: (2018) -
A multicenter randomized controlled study of an extracorporeal cytokine hemoadsorption device in septic patients
por: Schädler, D, et al.
Publicado: (2013)